PRESS RELEASE
News
-
-
PRESS RELEASE
Redwood AI Announces Collaboration with Resilience Biosciences Inc. to Advance AI-Assisted Small-Molecule Drug Development
Redwood AI Corp. collaborates with Resilience Biosciences Inc. for AI-assisted computational chemistry workflows to enhance small-molecule drug development. The partnership aims to streamline early discovery work in the life sciences sector -
-
PRESS RELEASE
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
Nanobiotix fully exercises underwriters' over-allotment option, raising gross proceeds of approximately $100 million from global offering. Proceeds allocated for development and general corporate purposes -
PRESS RELEASE
Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Abivax reports Q1 2026 financial results and interim data from UC Study 108, showing strong clinical remission with obefazimod. Cash position at €491.6M. Updates on upcoming trials and financial highlights -
-
-
PRESS RELEASE
PREATONI Group, an international group specializing in tourist resorts ownership and operations and real estate development, announces the Q1 2026 revenue for its subsidiary Pro Kapital Grupp
PREATONI Group's subsidiary AS Pro Kapital Grupp reports Q1 2026 revenue growth in real estate development projects in Estonia, Latvia, and Lithuania. Financial indicators show improvement -
-
